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Abstract
Background: The increasing incidence of community acquired infection due to Extended-Spectrum Beta-
Lactamase (ESBL) -Producing Enterobacteriaceae represent a great concern because there are few therapeutic
alternatives. The fecal flora of children in the community can represent a reservoir for ESBLs genes which are
located on highly transmissible plasmids and the spread of these genes among bacterial pathogens is concerning.
Because intestinal carriage is a key factor in the epidemiology of ESBL-producing Enterobacteriaceae, the study of
the prevalence of these resistant bacteria and risk factors in young children is of particular interest.
Methods: We assessed the prevalence and risk factors of community-acquired faecal carriage of extended-
spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae in children aged from 6 to 24 months, by means of
rectal swabbing in community pediatric practices. Child’s lifestyle and risk factors for carriage of resistant bacteria
were noted.
Results: Among the 411 children enrolled, 4.6% carried ESBL-producing Enterobacteriaceae. CTX-M-1, CTX-M-15
and CTX-M-14 were the predominant ESBLs. The 18 E. coli isolates were genetically heterogeneous. Recent
third-generation oral-cephalosporin exposure was associated with a higher risk of ESBL carriage (AOR=3.52,
95% CI[1.06-11.66], p=0.04).
Conclusions: The carriage rate of ESBL-producing Enterobacteriacae in young children in the French community
setting is noteworthy, underlining the importance of this population as a reservoir. Exposure to third-generation
oral cephalosporins was associated with a significant risk of ESBL carriage in our study. Because of the significant
public health implications including the treatment of community-acquired urinary tract infections, the spread of
organisms producing ESBLs in the community merits close monitoring with enhanced efforts for surveillance.
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Background
In the past decade there has been an alarming upsurge
in antibiotic-resistant Enterobacteriaceae producing
extended-spectrum β-lactamases (ESBL), due at least
partly to overuse of broad-spectrum cephalosporins [1].
The spread of mobile ESBL genes among bacterial
pathogens is of great concern, not only because these
enzymes confer resistance to oxy-imino-cephalosporins
and other β-lactam antibiotics, but also because they are
located on plasmids that confer resistance to other anti-
microbial agents, leaving very few treatment options.
CTXM–type ESBLs have now supplanted TEM and
SHV-type ESBLs both in nosocomial and community
settings [1] and Escherichia coli has replaced Klebsiella
spp. as the predominant species of ESBL-producing
Enterobacteriaceae [1].
Until recently, most infections caused by ESBL-
producing E. coli were hospital-acquired. blaCTX-M genes
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originate from environmental bacteria but have migrated
to highly transmissible plasmids, which have been linked
to ESBL circulation in the community. The community
can thus represent a reservoir for ESBLs not yet detected
in clinical isolates [2]. Colonisation in the intestinal
compartment by ESBL-producing isolates has been asso-
ciated with a high risk for developing infection due to
ESBL producers [3]. Prevalence of ESBL-carriage in chil-
dren varies depending on studies and geographical areas.
It ranges from 0,1% in Bolivie and Perou [4] to 31% in
Niger [5]. Because intestinal carriage is a key factor in
the epidemiology of ESBL-producing E. coli infection
[6], we investigated the prevalence of community-
acquired faecal carriage of ESBL-producing Enterobac-
teriaceae in children aged between 6 and 24 months pre-
senting to community paediatricians.
Methods
This work was an ancillary study of a nasopharyngeal
carriage study conducted in France following implemen-
tation of the 7-valent pneumococcal conjugate vaccine
[7]. Between October 2010 and March 2011, 18 French
pediatricians located in three regions (Ile de France,
Lorraine, and Provence-Alpes-Côte d’Azur) took part in
this prospective study.
A rectal sample was obtained from children aged 6 to
24 months, either during routine check-ups with normal
findings, or when they presented with acute otitis media
(AOM). The exclusion criteria were antibiotic treatment
whatever the antibiotic was within 7 days before enrol-
ment and severe underlying disease. Once their written
informed consent had been granted, we queried the parents
or guardians on the child’s demographics, risk factors for
carriage of resistant bacteria including use of any antibiotics
(between 7 days to 3 months before enrolment), daycare
modalities (daycare center, home or child minder), previous
hospitalization (during the previous 6 months), and
immunization history (pneumococcal conjugate vaccine).
The study was approved by the Saint Germain en Laye
Hospital Ethics Committee.
On inclusion, rectal samples were taken with a flexible,
sterile, soft rayon swab tip. After sampling, the swabs
were immediately inoculated in transport medium
(Copan, Brescia, Italy) at room temperature and sent
within 48 hours to the National E. coli and Shigella
Reference Center-associated laboratory at Robert Debré
Hospital, Paris. The rectal swabs were spread on ChromID
ESBL screening medium to screen the stool flora for cef-
podoxime resistance (bioMérieux, La Balme-les-Grottes,
France). ESBL detection was performed using the double-
disk synergy test between clavulanic acid and extended
spectrum-cephalosporins (ceftazidime and cefotaxime) [8].
Bacterial identification was performed with the API20E
system (bioMérieux, Marcy l’Etoile, France).
Multiplex PCR was used to characterize ß-lactamase
genes (including blaCTX-M, blaSHV, blaTEM and blaOXA-1),
with previously described methods and primers. Ampli-
cons were then sequenced [9,10]. Clonal relationships
among E. coli isolates were identified by semi-automated
rep-PCR (Diversilab, bioMérieux, France) [11]. The
strains were assigned to one of the four main E. coli
phylogenetic groups (A, B1, B2 and D), using a previ-
ously described multiplex PCR-based method [12].
Data were double-entered using 4D software (ver-
sion 6.4), and analyzed using Stata SE 9.1 (Stata
Corp., College Station, TX, USA) for univariate ana-
lysis and multivariate logistic regression (odds ratios
[ORs] and 95% confidence intervals [CI]). The Pear-
son Chi-square test was used in univariate analysis to
identify factors related (p<0.10) to ESBL-producing
Enterobacteriaceae carriage. Variables identified by
univariate analysis were age (continuous variable after
testing linearity), the study group (healthy controls vs
children with AOM) and recent antibiotic treatment
(within 3 months before enrolment).
Results
ESBL carriage was assessed in 411 children none of
whom were born preterm. Mean age of the children was
13.3±6.1 months, the sex ratio was 1.07 (M/F). 37.2% of
the children attended daycare centers, others were cared
for at home, 54.5% had siblings, and 34.1% had received
antibiotics within 7 days to 3 months before enrolment.
Third-generation oral cephalosporins (O3GC) repre-
sented 25% of the antibiotics prescribed and especially
cefpodoxime proxetil. ESBL-producing Enterobacteriaceae
were found in 19 patients (4.6%): 1 patient with E. coli
and Citrobacter freundii, 1 with K. pneumoniae, and 17
with E. coli. None of these children had been hospitalized
in the previous 6 months. ESBL-producing Enterobacter-
iaceae carriage was not related to daycare modalities. The
rate of ESBL-producing Enterobacteriaceae carriage was
higher in children with recent O3GC exposure (11.1%) than
in those without recent antibiotic exposure (4.4%) or with
recent aminopenicillin exposure (3.3%) (univariate analysis:
OR=3.00, 95% CI [0.94–9.58]). The risk of ESBL-producing
Enterobacteriaceae carriage was also higher among children
over 1 year old than in younger children (6.5% versus 2.5%,
respectively; OR=2.69, 95% CI [0.95–7.61]).
After adjustment in a logistic regression model, recent
O3GC use was associated with a significant risk of ESBL
carriage (Adjusted Odds Ratio (AOR) =3.52, 95% CI
[1.06-11.66], p=0.04). Table 1 shows the bacterial species,
the E. coli phylogenetic groups, the ESBLs produced,
other ß-lactamase genes, and associated resistance patterns.
Phylogenetic group A (9/18) predominated, and the most
frequent ESBL was CTX-M-1 (9/20). 11/16 of the CTX-M-
producing E. coli carried one other β-lactamase-encoding
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gene (mainly TEM-1) and 14/16 were resistant to at least
one other antibiotic family. Figure 1 shows the genetic het-
erogeneity of the ESBL-producing E. coli; 17 different pro-
files were found among the 18 isolates with a cut-off for
genetic relation of 97%.
Discussion
ESBL-producing Enterobacteriaceae are recognized as
important nosocomial pathogens in children, and are
often associated with outbreaks [13]. Screening for intes-
tinal carriage is crucial to predict the risk of ESBL infec-
tion, as the colon serves as a reservoir for extra-intestinal
pathogenic E. coli [14-16]. ESBL-producing E. coli have
previously been described as community-acquired in
adult patients [17]. The rate of ESBL-producing- E. coli
carriage in healthy subjects were 3.7% and 5.8% in a
Spanish [2] and Swiss study [18], respectively. Detection
of ESBL in fecal isolates from healthy children has also
been previously reported. Pallecchi et al. detected
ESBL-producing Enterobacteriaceae in 4 (0.1%) of 3208
children, and molecular characterization revealed the
presence of CTX-M type β-lactamase genes in the isolates
from all 4 children [4]. Recently, Guimaraes et al. studied
fecal carriage of ESBL-producing Enterobacteriaceae in
112 healthy children and found that 3 (2.6%) harbored
ESBL-producing E. coli (CTX-M-1, TEM-52 and SHV-12)
[19]. These isolates belonged to phylogenetic groups A,
B1 and D, respectively [19]. In our study, 4.6% (19/411) of
children aged from 6 to 24 months carried ESBL-
producing Enterobacteriaceae. The prevalence of carriage
of ESBL-producing Enterobacteriaceae is probably under-
estimated in this study because children with antibiotic
treatment within 7 days before enrolment and severe
underlying disease were excluded from the study. How-
ever, the percentage of children carrying ESBL-producing
Enterobacteriaceae strains in our population of children is
comparable to the percentage of ESBL-producing-E. coli
isolated from urinary tract infection in pediatric patients
found in France (data on file). Most of the isolates of our
study (18/20, 90%) produced a CTX-M type ESBL, and
were resistant to multiple antibiotic classes (Table 1).
Virulent extra-intestinal strains of E. coli belong to phylo-
genetic group B2 and, to a lesser extent, group D, whereas
commensal strains mainly belong to group A or B1 [20].
Most of our ESBL-producing E. coli isolates belonged to










1 E. coli A CTX-M-1 TEM-135 NONE
2 E. coli A CTX-M-1 TSU,NA
7 E. coli A CTX-M-1 TEM-1 TSU, GT
19 E. coli A CTX-M-1 TEM-1 TSU, NA, CIP
20 E. coli A CTX-M-1 TEM-1 TSU, NA, KA
8 E. coli A CTX-M-15 TEM-1 TSU, NA, GT,TM
11 E. coli A CTX-M-15 OXA-1 TSU, NA, CIP, K, GT, TM
3 E. coli A SHV-12 NA
21 E. coli A TEM-52 TSU, NA
9 E. coli B1 CTX-M-1 TEM-1 TSU
15 E. coli B1 CTX-M-1 TSU
14 E. coli B2 CTX-M-15 TSU, NA, CIP, K, GT, TM
13 E. coli D CTX-M-1 TSU, NA, CIP
22 E. coli D CTX-M-1 TEM-1 TSU, NA
6 E. coli D CTX-M-14 NA
12 E. coli D CTX-M-14 TEM-1 NA
18 E. coli D CTX-M-27 TEM-1 TSU, NA, CIP
16 E. coli** D CTX-M-32 TEM-1 NONE
C. freundii** CTX-M-32 NONE
K. pneumoniae CTX-M-14 SHV-1 TSU
*TSU, trimethoprim-sulfamethoxazole; NA, nalidixic acid; CIP, ciprofloxacin; GT,gentamicin; KA, kanamycin; TM, tobramycin.
**same patient.
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group A/B1, possibly because of greater antibiotic exposure
of group A/B1 strains belonging to the fecal flora [21].
Interestingly, one group A E. coli strain isolated here car-
ried a TEM-52 ESBL. Neonatal meningitis caused by TEM-
52-producing group A E. coli was recently described [13].
Rep-PCR showed a high level of genomic diversity among
the 18 E. coli isolates, illustrating the high capacity for
spread among different genetic backgrounds found in the
community, via mobile conjugative elements. Exposure to
third-generation oral cephalosporins was associated with a
significant risk of ESBL carriage in our study (AOR=3.52,
95% CI [1.06-11.66], p=0.04). These results support efforts
to reduce prescribing of cephalosporins for control of re-
sistant Enterobacteriaceae not only for the treatment of
urinary tract infection (UTIs) but also upper respiratory
infection.
Conclusion
The carriage rate of ESBL-producing Enterobacteriaceae in
young children in the French community setting (4.6%) is
noteworthy, underlining the importance of this population
as a reservoir [22].
Exposure to third-generation oral cephalosporins was asso-
ciated with a significant risk of ESBL carriage in our study.
Because of the significant public health implications including
the treatment of community-acquired UTIs, the spread of
organisms producing ESBLs in the community merits close
monitoring with enhanced efforts for surveillance.
Figure 1 Genetic diversity of ESBL-producing E. coli. Dendrogram showing the genetic heterogeneity of ESBL-producing E. coli. 17 different
profiles were found among the 18 isolates with a cut-off for genetic relation of 97%.
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